Blood pressure meds recalled for trace amounts of carcinogen


The Food and Drug Administration is warning people of another recall involving blood pressure medication.

Aurobindo Pharma USA has recalled 80 lots of Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets USP, and Valsartan Tablets USP due to trace amounts of N-nitrosodiethylamine, a substance that has been classified as a probable human carcinogen, the FDA said.

The company has received no reports of adverse events related to the recall.

The FDA said people prescribed the drugs should continue taking them because the risk of harm may be higher if treatment is stopped immediately without alternative treatment. People should contact their pharmacist or physician about an alternative treatment prior to returning the medication.

The products subject to recall are listed on the FDA’s website.

, patients currently taking the tablets listed in the recall should not stop taking their medication. The FDA said the health risk is higher if the treatment is stopped immediately without any alternative treatment.

Patients taking the medication should, however, contact their pharmacist or physician. Consumers with medical questions regarding this recall can contact Aurobindo Pharma USA, Inc. at 1-866-850-2876 or

Copyright 2020 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Top Stories

More Top Stories

Latest Videos

Don't Miss